1. The new opportunities in medicinal chemistry of fourth‐generation EGFR inhibitors to overcome C797S mutation;He J.;Euro. J. Med. Chem.,2021
2. Emerging strategies to overcome resistance to third‐generation EGFR inhibitors;Shi K.;J. Hematol. Oncol.,2022
3. clinicaltrials.gov.
4. Gefitinib–a novel targeted approach to treating cancer;Herbst R. S.;Nat. Rev. Cancer.,2004
5. Targeting the EGFR signaling pathway in cancer therapy;Seshacharyulu P.;Expert Opin. Ther. Targets.,2012